ĂŰĚŇ´«Ă˝app

Home

Dr. David Roberge

Academic title(s): 

Adjunct Professor, Oncology 

Dr. David Roberge
Contact Information
Email address: 
david.roberge [at] mcgill.ca
Department: 
Oncology
Division: 
Surgical and Interventional Sciences
Degree(s): 

MD

Graduate supervision: 

Currently supervising students

Group: 
Currently Recruiting
M.Sc. Students
M.Sc. Non-Thesis projects
Ph.D. Students
Research areas: 
Surgical Outcomes and Quality
Surgical Oncology
Current research: 

Stereotactic body radiation therapy / radiosurgery; Sparing of radiation induced alopecia; Radiation chemosensitization; Imaging of sarcopenia; Treatment of cutaneous lymphoma; Quantitation of radiation toxicity; Treatment of brain metastases 

Areas of interest: 

 Radiation Oncology 

Biography: 

Dr. David Roberge is a Full Professor at the University of Montreal and Adjunct Professor at McGill University. He is a graduate of the McGill residency program in radiation oncology and completed post-residency fellowships at Stanford University and St. Jude Children’s Research Hospital. Currently, he is a clinician-researcher at CHUM (Centre hospitalier de l’Université de Montréal) in Montreal. 

Dr. Roberge's clinical research spans a wide range of cancers, including soft tissue sarcoma, cutaneous lymphoma, and pediatric oncology. However, he has a particular focus on brain tumors, especially those treated with radiosurgery. His research also includes post-operative treatments for brain metastasis, the conservative management of brain arteriovenous malformations, and the use of palliative radiotherapy for hepatic cancer. Dr. Roberge has contributed to key studies in radiation oncology, including the use of short-course radiotherapy in pancreatic cancer and novel approaches for targeting HER2+ solid tumors with radioligands. His work continues to drive advancements in cancer treatment and radiotherapy techniques. 

Selected publications: 

Back to top